Tumor Associated Antigens - Pharma

Relevant Publications

Reconstitution of peripheral blood T cell receptor β immune repertoire in immune checkpoint inhibitors associated myocarditis.

Issue Release: 2024

Programmable melanoma-targeted radio-immunotherapy via fusogenic liposomes functionalized with multivariate-gated aptamer assemblies.

Issue Release: 2024

Oxidized Melanoma Antigens Promote Activation and Proliferation of Cytotoxic T-Cell Subpopulations.

Issue Release: 2024

Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes.

Issue Release: 2024

Pan-cancer proteogenomics expands the landscape of therapeutic targets.

Issue Release: 2024

Single-Domain Antibodies as Antibody-Drug Conjugates: From Promise to Practice-A Systematic Review.

Issue Release: 2024

Tumor-Suppressive Cross-Linking of Anti- Antibodies in Acute Lymphoblastic Leukemia.

Issue Release: 2024

Precise Regulation of Reactive Oxygen Species in Tumor Microenvironment for Alleviating Inhibitory Immunogenic Cell Death.

Issue Release: 2024

Engineered Antibodies as Cancer Radiotheranostics.

Issue Release: 2024

Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions.

Issue Release: 2024

The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review).

Issue Release: 2024

Beyond BCMA: newer immune targets in myeloma.

Issue Release: 2024

Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events.

Issue Release: 2024

TME-Triggered Degradable Phototheranostic Nanoplatform for NIR-II Fluorescence Bioimaging-Guided Phototherapies and Immune Activation.

Issue Release: 2024

Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy.

Issue Release: 2024

The Impact of High Intensity Focused Ultrasound (HIFU) on Tumor-Specific Immune Responses of Prostate Cancer.

Issue Release: 2024

Immunostimulatory effects of thermal ablation: Challenges and future prospects.

Issue Release: 2024

Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity.

Issue Release: 2024

T-Cell Engagers-The Structure and Functional Principle and Application in Hematological Malignancies.

Issue Release: 2024

Acidity-responsive polyphenol-coordinated nanovaccines for improving tumor immunotherapy bidirectional reshaping of the immunosuppressive microenvironment and controllable release of antigens.

Issue Release: 2024

How Does Pharma Play a Role in Chronic Conditions?

What are the Key Challenges?

Why is Generic Competition Important?

What is Pharma?

What Education and Training Do Pharmacists Need?

How Do Pharmacists Contribute to Patient Care?

Why is Patient Education Important?

Who are Pharmacists?

What Should Be Included in Patient Education Materials?

How Can Technology Aid in Patient Education?

Partnered Content Networks

Relevant Topics